| Indian Journal of Medical Ethics | ||||||
![]() Home Current Issue Past Issues Support About IJME Oct-Dec2001-9(4) |
FROM THE PRESS Stem cells from India India is tightening regulations on research on
human embryonic stem cells to prepare for research within the country as well as
possible international projects that might involve embryonic material from
India. This follows concern that India could emerge as a major source of
embryonic stem cells as there is almost no public or religious debate on
abortion, which is legal across India. A national bioethics panel, set up by India's
department of biotechnology, has drafted new guidelines for human genomics
research that also cover rules for the collection and use of embryonic stem
cells. The panel said that scientists may harvest human embryos for research
before day 14 of gestation with the informed consent of the donor. All projects
would have to be approved by the national bioethics panel, and researchers would
have to share any commercial benefits that emerge from embryonic stem cell lines
with the donor. Senior officials say that the new rules draw on
existing ethical guidelines from the Indian Council of Medical Research but that
they will be enforceable. "They have been approved by the law ministry and
are intended to be legally binding," said Dr Virender Vinayak, adviser for
medical research in the department of biotechnology. Two Indian research centres
are among 10 worldwide named by the US National Institutes of Health as holding
human stem cell lines that are eligible for US federal research funds.
Government officials have said they may need to regulate in vitro fertilisation
clinics that are potential sources of embryonic stem cells. Ganapati Mudur. India to tighten rules on human
embryonic stem cells research BMJ September 8, 2001. AIIMS doing a bad job India's leading public hospital and medical
education centre has failed to provide high quality medical services to its
patients, a government audit report has said. A shortage of doctors and infrastructure
deficiencies at the All India Institute of Medical Sciences, New Delhi, is
depriving patients of quality time in diagnosis and medical care, the report by
India's auditor general said. An outpatient at the institute on average gets four
to nine minutes of attention from a doctor, while the waiting time for surgery
ranges from two to 34 months, it said. And at least three patients terminally
ill with cancer are turned away each day for lack of healthcare facilities.
The report also said the institute failed to
nurture trained medical professionals and stop the 'brain drain'. The government
subsidises medical education at the institute, but 49 per cent of a sample of
390 doctors who had trained there had emigrated. "The patient load we get is the price we're paying
for our efficiency," said Dr Pradeep Kumar Dave, director of the institute. The
outpatient department, originally designed to cater for 500 patients a day, now
receives nearly 6,000 each day. The institute is India's most attractive site for
medical education, with more than 35,000 candidates taking a screening
examination for the institute's undergraduate medical degree programme that
accepts 50 students each year. Dr Dave said that the institute could not be
expected to exercise control over students who prefer to emigrate. Health policy
analysts say that the situation at the institute merely exemplifies the
deterioration of health care services in the government sector. "An institution
intended for tertiary care has been reduced to a general hospital," said Alok
Mukhopadhyay, executive director of India's Voluntary Health Association.
Ganapati Mudur. Auditors slate top Indian
medical centre. BMJ September 8, 2001. 'But it was legal
then...' The law is clear: you cannot conduct or 'cause to
conduct' a test to find out the sex of your foetus. If you do so, you can be
imprisoned for up to three years. But the Prenatal Diagnostic Techniques (PNDT)
Regulation Act came into effect only five years ago, and that's why a couple in
Surat and their doctors are very lucky. For not only did they determine the sex of the
foetus, they aborted it when told it was female. After the abortion, when the
parents discovered that the foetus was male, they dragged the doctors to the
consumer court and were recently awarded damages with interest. In October 1992,
Rita Jadhav, resident of Dhova village in Bhavnagar and a mother of three
daughters, wanted a male child and so she consulted gynaecologist Sushma Iyer
when she became pregnant for the fourth time. Iyer sent the uterine fluid sample
to Surat-based pathologist Nirmal Vaniwala who identified the foetus as a
female. The couple came back to Iyer saying they wanted a
second test to confirm the findings but Iyer suggested an abortion going by
Vaniwala's report. The couple could not afford Iyer's abortion fees so
they went to the local SDVS Ashaktashram hospital and had an abortion done. The
doctor who conducted the abortion told them the foetus was a male. The distressed couple approached Jagrut
Nagrik, a consumer-protection organisation in Vadodara, and filed a case against
the Surat-based gynaecologist and pathologist with the State Consumer Disputes
Redressal Commission. They acused the doctors of negligence and violation of
medical ethics. PV Moorjani, Jagrut Nagrik secretary who filed the case, claimed
a compensation of just over Rs 10 lakh. The commission, in its order in July, observed that
there was collusion between the gynaecologist and the pathologist which
prevented a second test. The commission also observed that both the doctors were
registered with the Medical Council and had performed a sex determination test
though it was against medical ethics, and this amounted to medical
negligence. The two doctors were directed to pay Rs 25,000 with
10 per cent interest within four weeks of the order to the parents. "We have only seen the case from the scientific
point of view and the doctor should have conducted the test carefully," said
Justice Mahendrabhai Parikh, chief of the commission who delivered the verdict.
Justice Parikh declined to comment on the case saying that the judgement speaks
for itself and only the High Court can take up the matter. He added that in this
particular case the "sex determination test may have been done before it was
banned." Under existing law the story would have been quite different. "This is
a criminal case and both the parents and the doctors can be imprisoned and fined
for breaking the law," says A R Nanda, union secretary of family welfare.
For not only are sex determination tests 'against
medical ethics', as the commission has noted in its judgement, the PNDT Act
clearly makes it illegal. It notes that prenatal procedures should be only done
to determine 'chromosomal abnormalities, genetic metabolic disease,
haemoglobinopathies, sex-linked genetic diseases and congenital abnormalities',
and that "no person conducting prenatal diagnostic procedures shall communicate
to the pregnant woman concerned or her relatives the sex of the foetus by words,
signs or in any other manner." Under the offences and penalties section, the Act
says that the guilty shall be punished with imprisonment for a term which may
extend to three years with fine which may extend to Rs 10,000. Under the Act,
not only are the doctors guilty for telling the parents the sex of the foetus,
but the parents are as guilty of seeking the sex determination test for the
obvious purpose of aborting the girl child. "There is clear evidence against both the doctors
and the parents in the case and the appropriate authorities, who are empowered
to implement the PNDT Act, should take action against both parties for breaking
the law," says Nanda. Ayesha Khan and Sanchita Sharma. When foeticide
gets you money from the court. Indian Express, August 5, 2001. Kidney trade In response to a petition filed in the Bombay High
Court by surgeon Dr Mahesh Jukar, challenging the nine charges framed against
him by a lower court, for illegal kidney transplantation, the state argued that
there was substantial evidence to prove that Dr Jukar was actively involved in
illegal surgeries and pointed out evidence that warrants
conviction. The case refers to a flourishing kidney
transplantation racket at an Ayurvedic dispensary by the name of Kaushalya
Nursing Home in Linking Road, Khar, which was owned by Dr Santosh Raut, main
accused in the case. The dispensary was started in 1989 and Dr Raut, through
agents, would bring people from Gulf countries for kidney transplantation.
Agents would, under false excuses, also bring donors - who would in most cases
be illiterate and poor people. While the donors would get Rs 40,000, Dr Raut
would get money in dollars. The amount received by the agents would be between
Rs 30,000 and Rs 35,000 while Dr Raut would get anything between Rs 2.5 lakh and
Rs 3.75 lakh. The patients would come from countries like Turkey, Greece, Saudi
Arabia, Yugoslavia, etc. Prior to 1994, Dr Raut had a surgeon by the name of
Dr Yogesh Kothari to help him in the transplantation as Dr Raut himself was not
a qualified surgeon. The dispensary also had no license for surgery. From 1994
onwards, Dr Raut employed two surgeons - Dr Mahesh Jukar and R Abhay Dalvi - to
do the transplantation. Dr Dalvi was attached to KEM hospital. Besides these two
surgeons, Dr Vishwas Sane and Dr Dilip Rana were employed as anaesthetists. The
modus operandi would be simple - while Dr Jukar attended to the donor to remove
the kidney, Dr Dalvi and Dr Raut would be with the recipient.
Approximately 225 cases were done in this manner by Dr Raut. After the dispensary was raided by the crime branch
and various charges were filed, Dr Jukar approached the court for a
discharge. He stated that he was a young man in the beginning of his career and
he used to go for surgery to learn from other doctors. He also argued that it
was not his dispensary and he used to go only when he was called and, hence, the
prosecution should not be believed and he should also be discharged. Among the
evidence the prosecution pointed to was that the register showed that more than
100 cases were done by Dr Jukar, all referred by Dr Raut. Correspondent. State defies surgeon plea, says
evidence proves the crime: illegal transplant racket. Asian Age, August 13,
2001. Call to probe trials The Consumer Education and Research Society (CERS),
Ahmedabad, has petitioned the National Human Rights Commission (NHRC) for a
probe into testing of experimental drugs on unsuspecting patients in violation
of ethical and medical norms. The CERS petition follows reports of more than 20
clinical evaluations of new drugs being conducted in India, on human subjects
and patients. Many of these studies were unauthorised and not properly monitored
by competent regulatory medical or ethics bodies, it added. In fact, the
patients or the persons on whom the drugs were being tested were not made aware
of the risks involved. "It is highly unethical to carry out clinical
trials on humans without explaining to them the risks involved in a language
they understand and their consent taken in writing before witnesses," CERS said.
In this connection, it referred to the tests conducted on the 'hapless patients'
at the Regional Cancer Centre (RCC) at Thiruvananthapuram in Kerala and the
Metro Hospital in New Delhi. CERS also referred to New Delhi's metro hospital
where Dr Purshottam Lal injected vascular endothelial growth factor into 11
heart patients without informing them of the risks involved. In a press release, CERS pointed out that the
Indian Council of Medical Research (ICMR) has adopted elaborate ethical
guidelines for biomedical research including clinical trials on humans and said
these tests have to be undertaken with the prior permission of the DGCI.
Further, the clinical tests are to be monitored at the site of the test by an
appropriately constituted institutional ethics committee (IEC). "CERS is concerned about the alleged human rights
violation of the patients who have received these experimental drugs without
their written consent, without their knowledge and without following the
established guidelines for these tests and of course, prior permission of the
DGCI. It is possible that the IEC did not perform its expected duty by strictly
monitoring these clinical studies on patients," the petition said. Though the Kerala state government has constituted
an enquiry under Dr Purvesh Parikh to look into the RCC experiments, the NHRC
will have to investigate the issue in its entirety, CERS said. It called upon the NHRC to see that the DGCI
submits a list of all the clinical trials being conducted on humans and the
names of the clinical centres where these are conducted in the
country. Times News Network. NHRC urged to investigate
testing of drugs on patients. The Times of India, August 28,
2001. Without comment Union health minister Dr C P Thakur has made a very
strange request to the finance ministry: exempt all doctors in Bihar from paying
income tax as they were paying 'protection money' to criminals in the state. Dr
Thakur also appealed to Union home minister L K Advani to intervene and protect
the doctors and common man in Bihar. UNI. 'Bihar doctors must get tax exemption'.
Asian Age, September 28, 2001. |
|||||
|
| ||||||